ELEKT-D protocol
Open this page in the complete interactive Atlas
Provides eligibility, interventions, primary outcome and trial history.
Where this source fits
Ketamine · Treatment-resistant major depression without psychosis
In ELEKT-D, 55.4% of participants assigned to ketamine and 41.2% assigned to ECT met the short-term threshold for improvement in self-rated depression. Ketamine met the study’s prespecified noninferiority criterion.
The study enrolled patients with nonpsychotic major depression referred for ECT. It cannot establish ketamine’s equivalence to ECT for catatonia. Psychiatric use of racemic ketamine is off-label in the U.S.
Reading basis · Original source summarized in the experimental-drug section